SCHEMBL4385972

SCHEMBL4385972

CCc1c(O)cc(O)c(-c2cccc(OCc3cccnc3)c2)c1CCOCC(O)CO

nearest known ligand 0.43

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GPR132 Q9UNW8 19/20 0.43
CMKLR2 P46091 1/20 0.39
CMKLR1 Q99788 1/20 0.39
HTR1A P08908 1/20 0.36
DRD2 P14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4386225 0.91 GPR132 (0.36) GPR132
SCHEMBL4388418 0.85 TSHR (0.40)
SCHEMBL4382193 0.84 GPR132 (0.37) GPR132HTR1ADRD2
SCHEMBL4388631 0.82 TSHR (0.46)
SCHEMBL4387012 0.81 ESR1 (0.39)
SCHEMBL4384087 0.80 CHEK1 (0.36)
SCHEMBL4396308 0.79 CYP1A2 (0.42) HTR1ADRD2
SCHEMBL4392407 0.77 CYP1A2 (0.36)
SCHEMBL4382721 0.77 USP7 (0.36)
SCHEMBL4394865 0.76 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed
EP-1704856-A1 HSP90 FAMILY PROTEIN INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P GPR132 2144/4885CMKLR2 4282/4885CMKLR1 3902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.